Engineered “mini livers” could be injected as an alternative to transplantation
SMRTR summary
MIT researchers developed injectable "mini livers" — hepatocyte cells bundled with hydrogel microspheres — that form connections with blood vessels once inside the body. Tested in mice for two months, this could offer liver disease patients an alternative to transplant surgery or serve as a bridge while awaiting a donor organ.
SMRTR provides this summary for quick context. The original article belongs to MIT Technology Review.
Read the original article